NCT01289015已完成3 期
A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 855
- 试验地点
- 23
- 主要终点
- Complete Cure of Interdigital Tinea Pedis
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with tinea pedis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males or non-pregnant females, ≥12 years of age, of any race or sex. Females of child-bearing potential must have a negative urine pregnancy test.
- •Presence of interdigital only or both interdigital and moccasin types of tinea pedis on one or both feet characterized by clinical evidence of a tinea infection (at least moderate erythema, moderate scaling and mild pruritus) based on signs and symptoms in the affected area(s)).
排除标准
- •Subjects with life-threatening condition (ex. autoimmune deficiency syndrome, cancer,unstable angina or myocardial infarction) within the last 6 months.
- •Subjects with abnormal findings - physical or laboratory - that are considered by the investigator to be clinically important and indicative of conditions that might complicate interpretation of study results.
- •Subjects with a known hypersensitivity to study drugs or their components.
- •Subjects who have a recent history or who are currently known to abuse alcohol or drugs.
- •Uncontrolled diabetes mellitus.
- •Hemodialysis or chronic ambulatory peritoneal dialysis therapy.
- •Current diagnosis of immunocompromising conditions.
- •Foot psoriasis, corns and/or callus involving any web spaces, atopic or contact dermatitis.
- •Severe dermatophytoses, onychomycosis (on the evaluated foot), mucocutaneous candidiasis or bacterial skin infection.
- •Extremely severe tinea pedis (incapacitating).
- •Female subject who is pregnant or lactating, who is not using or does not agree to use an acceptable form of contraception during the study, or who intends to become pregnant during the study
研究组 & 干预措施
NAFT-600 ( naftin 2 % gel)
Experimental
干预措施: NAFT-600 ( naftin 2 % gel ) (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Complete Cure of Interdigital Tinea Pedis
时间窗: Visit 4/ Week 6
The primary efficacy comparison between NAFT-600 gel and placebo will be based on the percentage of subjects at Week 6 with complete cure of interdigital tinea pedis. Complete cure is defined as negative mycology results (dermatophyte culture and KOH) and the absence of erythema, scaling, and pruritus.
次要结局
- Effective Treatment and Mycological Cure of Interdigital Tinea Pedis at Week 6(Visit 4/ Week 6.)
研究者
研究点 (23)
Loading locations...
相似试验
已完成
3 期
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea PedisAthlete's FootTinea PedisNCT00750139Merz North America, Inc.707
已完成
3 期
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea CrurisJock ItchTinea CrurisNCT00750152Merz North America, Inc.334
已完成
3 期
Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)Chronic Obstructive Pulmonary DiseaseNCT01854645Pearl Therapeutics, Inc.2,103
已完成
3 期
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea CrurisJock ItchTinea CrurisNCT01885156Merz North America, Inc.65
已完成
2 期
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaSchizophreniaNCT04158687Concert Pharmaceuticals326